Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact

Subscribe

Registers› Irish medicines ›Telmisartan

Medicines register · Ireland

Telmisartan — medicines in Ireland

70 authorised products containing Telmisartan, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Actelsar HCT 40 mg/12.5 mg tablets EU/1/13/817/001-013

Hydrochlorothiazide, Telmisartan

Actavis Group hf

—

Actelsar HCT 80 mg/12.5 mg tablets EU/1/13/817/014-028

Hydrochlorothiazide, Telmisartan

Actavis Group hf

—

Actelsar HCT 80 mg/25 mg tablets EU/1/13/817/029-041

Hydrochlorothiazide, Telmisartan

Actavis Group hf

—

Kinzalkomb 40 mg/12.5 mg tablets EU/1/02/214/1-5

Telmisartan, Hydrochlorothiazide

—

Kinzalkomb 80 mg/12.5 mg tablets EU/1/02/214/006-010

Telmisartan, Hydrochlorothiazide

—

Kinzalkomb 80 mg/25 mg tablets EU/1/02/214/11-15

Hydrochlorothiazide, Telmisartan

—

Kinzalmono 20 mg tablets EU/1/98/091/009-012

Telmisartan

—

Kinzalmono 40 mg tablets EU/1/98/091/001-004

Telmisartan

—

Kinzalmono 80 mg tablets EU/1/98/091/005-008

Telmisartan

—

Micardis 20 mg tablets EU/1/98/090/009-012

Telmisartan

Boehringer Ingelheim International GmbH

—

Micardis 40 mg tablets EU/1/98/090/001-004

Telmisartan

Boehringer Ingelheim International GmbH

—

Micardis 80 mg tablets EU/1/98/090/005-008

Telmisartan

Boehringer Ingelheim International GmbH

—

MicardisPlus 40 mg/12.5 mg tablets EU/1/02/213/001-005

Telmisartan, Hydrochlorothiazide

Boehringer Ingelheim International GmbH

—

MicardisPlus 80 mg/12.5 mg tablets EU/1/02/213/006-010

Telmisartan, Hydrochlorothiazide

Boehringer Ingelheim International GmbH

—

MicardisPlus 80 mg/25 mg tablets EU/1/02/213/17-23

Telmisartan, Hydrochlorothiazide

Boehringer Ingelheim International GmbH

—

Mirpresoc 20 mg Tablets PA1239/017/001

Telmisartan

Laboratorios Liconsa S.A.

Not marketed

Mirpresoc 40 mg Tablets PA1239/017/002

Telmisartan

Laboratorios Liconsa S.A.

Not marketed

Mirpresoc 80 mg Tablets PA1239/017/003

Telmisartan

Laboratorios Liconsa S.A.

Not marketed

Pritor 20 mg tablets EU/1/98/089/011-014

Telmisartan

—

Pritor 40 mg tablets EU/1/98/089/001-005

Telmisartan

—

Pritor 80 mg tablets EU/1/98/089/006-010

Telmisartan

—

PritorPlus 40 mg/12.5 mg tablets EU/1/02/215/1-5

Telmisartan, Hydrochlorothiazide

—

PritorPlus 80 mg/12.5 mg tablets EU/1/02/215/006-010

Telmisartan, Hydrochlorothiazide

—

PritorPlus 80 mg/25 mg tablets EU/1/02/215/15-21

Hydrochlorothiazide, Telmisartan

—

Telmisartan 20 mg tablets PA22749/012/001

Telmisartan

Brillpharma (Ireland) Limited

Not marketed

Telmisartan 20 mg tablets PA25364/014/001

Telmisartan

Amarox Pharma B.V.

Not marketed

Telmisartan 20 mg Tablets PA2315/014/001

Telmisartan

Accord Healthcare Ireland Ltd.

Marketed

Telmisartan 40 mg tablets PA22749/012/002

Telmisartan

Brillpharma (Ireland) Limited

Not marketed

Telmisartan 40 mg tablets PA25364/014/002

Telmisartan

Amarox Pharma B.V.

Not marketed

Telmisartan 40 mg Tablets PA2315/014/002

Telmisartan

Accord Healthcare Ireland Ltd.

Marketed

Telmisartan 80 mg tablets PA22749/012/003

Telmisartan

Brillpharma (Ireland) Limited

Not marketed

Telmisartan 80 mg tablets PA25364/014/003

Telmisartan

Amarox Pharma B.V.

Not marketed

Telmisartan 80 mg Tablets PA2315/014/003

Telmisartan

Accord Healthcare Ireland Ltd.

Marketed

Telmisartan Actavis 20 mg tablets EU/1/10/639/001-010

Telmisartan

Actavis Group hf

—

Telmisartan Actavis 40 mg tablets EU/1/10/639/011-020

Telmisartan

Actavis Group hf

—

Telmisartan Actavis 80 mg tablets EU/1/10/639/021-030

Telmisartan

Actavis Group hf

—

Telmisartan Clonmel 20 mg film-coated tablets PA0126/228/001

Telmisartan

Clonmel Healthcare Ltd

Marketed

Telmisartan Clonmel 40 mg film-coated tablets PA0126/228/002

Telmisartan

Clonmel Healthcare Ltd

Marketed

Telmisartan Clonmel 80 mg film-coated tablets PA0126/228/003

Telmisartan

Clonmel Healthcare Ltd

Marketed

Telmisartan Fair-Med 20 mg Tablets PA1789/008/001

Telmisartan

Fairmed Healthcare GmbH

Not marketed

Telmisartan Fair-Med 40 mg Tablets PA1789/008/002

Telmisartan

Fairmed Healthcare GmbH

Not marketed

Telmisartan Fair-Med 80 mg Tablets PA1789/008/003

Telmisartan

Fairmed Healthcare GmbH

Not marketed

Telmisartan Rowa 20 mg tablets PA0074/078/001

Telmisartan

Rowa Pharmaceuticals Limited,

Marketed

Telmisartan Rowa 40 mg tablets PA0074/078/002

Telmisartan

Rowa Pharmaceuticals Limited,

Marketed

Telmisartan Rowa 80 mg tablets PA0074/078/003

Telmisartan

Rowa Pharmaceuticals Limited,

Marketed

Telmisartan Teva Pharma 20 mg tablets EU/1/11/719/001-020

Telmisartan

—

Telmisartan Teva Pharma 40 mg tablets EU/1/11/719/021-040

Telmisartan

—

Telmisartan Teva Pharma 80 mg tablets EU/1/11/719/041-060

Telmisartan

—

Telmisartan/Hydrochlorothiazide 40 mg/12.5 mg tablets PA2315/107/001

Telmisartan, Hydrochlorothiazide

Accord Healthcare Ireland Ltd.

Marketed

Telmisartan/Hydrochlorothiazide 80 mg/12.5 mg tablets PA2315/107/002

Telmisartan, Hydrochlorothiazide

Accord Healthcare Ireland Ltd.

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/substance/telmisartan

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.